New England Asset Management Inc Takeda Pharmaceutical CO LTD Transaction History

New England Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$16.55 - $18.64 $9,317 - $10,494	-563 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$16.71 - $19.9 $916,760 - $1.09 Million	-54,863 Reduced 98.98%	563 $10,000
Q3 2020 Nov 16, 2020	BUY	$17.1 - $19.19 $6,840 - $7,676	400 Added 0.73%	55,426 $989,000
Q1 2020 May 15, 2020	BUY	$13.02 - $20.31 $18,228 - $28,434	1,400 Added 2.61%	55,026 $835,000
Q2 2019 Aug 14, 2019	BUY	$16.58 - $20.49 $243,626 - $301,080	14,694 Added 37.74%	53,626 $949,000

Q1 2019 May 15, 2019	BUY	$16.7 - $21.52 $650,164 - $837,816	38,932 New	38,932 $793,000

338

76.2M

1.85M

121K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $41.5B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of New England Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on New England Asset Management Inc with notifications on news.